Pharmacoeconomic studies - Pitfalls and problems

被引：4

作者：

DeGraeve, D

Nonneman, W

机构：

来源：

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE | 1996年 / 12卷 / 01期

关键词：

D O I：

10.1017/S0266462300009351

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The literature on economic evaluation of pharmaceuticals is growing rapidly. Although there have been substantial methodologic advances, there remain serious problems and pitfalls. This presentation focuses on three aspects, i.e., use (and abuse) of evaluation studies, methodologic problems, and the quality of published studies.

引用

页码：22 / 30

页数：9

共 27 条

[1] ECONOMIC-ANALYSIS IN RANDOMIZED CONTROL TRIALS [J].

ADAMS, ME ;

MCCALL, NT ;

GRAY, DT ;

ORZA, MJ ;

CHALMERS, TC .

MEDICAL CARE, 1992, 30 (03) :231-243

[2] QALYS [J].

BROOME, J .

JOURNAL OF PUBLIC ECONOMICS, 1993, 50 (02) :149-167

[3] ECONOMIC-EVALUATION OF PHARMACEUTICALS - A EUROPEAN PERSPECTIVE [J].

DRUMMOND, M ;

RUTTEN, F ;

BRENNA, A ;

PINTO, CG ;

HORISBERGER, B ;

JONSSON, B ;

LEPEN, C ;

ROVIRA, J ;

VONDERSCHULENBURG, MG ;

SINTONEN, H ;

TORFS, K .

PHARMACOECONOMICS, 1993, 4 (03) :173-186

[4]

Drummond M, 1987, METHODS EC EVALUATIO

[5]

Drummond M F, 1992, Pharmacoeconomics, V1, P8, DOI 10.2165/00019053-199201010-00004

[6]

Drummond M F, 1991, Int J Technol Assess Health Care, V7, P561

[7]

GRAMLICH EM, 1990, GUIDE BENEFIT COST A

[8] GUIDELINES FOR THE CLINICAL AND ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES [J].

GUYATT, G ;

DRUMMOND, M ;

FEENY, D ;

TUGWELL, P ;

STODDART, G ;

HAYNES, RB ;

BENNETT, K ;

LABELLE, R .

SOCIAL SCIENCE & MEDICINE, 1986, 22 (04) :393-408

[9]

Henry D, 1992, Pharmacoeconomics, V1, P54, DOI 10.2165/00019053-199201010-00010

[10] AVOIDING BIAS IN THE CONDUCT AND REPORTING OF COST-EFFECTIVENESS RESEARCH SPONSORED BY PHARMACEUTICAL COMPANIES [J].

HILLMAN, AL ;

EISENBERG, JM ;

PAULY, MV ;

BLOOM, BS ;

GLICK, H ;

KINOSIAN, B ;

SCHWARTZ, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1362-1365

← 1 2 3 →